13周岁女孩可免费接种！HPV疫苗纳入国家免疫规划

Core Viewpoint - The HPV vaccine has been officially included in the National Immunization Program, allowing free vaccination for girls born after November 10, 2011, who are 13 weeks old or older, with two doses of the bivalent HPV vaccine administered six months apart [1][4]. Group 1: Health Impact - The incidence and mortality rates of cervical cancer in China have been rising, with younger age groups increasingly affected. Vaccination against HPV can effectively prevent high-risk HPV infections and reduce the occurrence of cervical cancer and related diseases [4]. - The inclusion of the HPV vaccine in the National Immunization Program aims to lower the disease burden caused by HPV infections and meet public health needs [4]. Group 2: Implementation and Monitoring - Various departments, including the Ministry of Industry and Information Technology and the National Medical Products Administration, are tasked with monitoring the production and supply of the HPV vaccine, ensuring stable production and timely resolution of issues faced by manufacturers [4][5]. - Local health authorities are required to establish management systems for vaccine storage and distribution, ensuring compliance with quality standards and preventing misuse [5]. Group 3: Demand and Accessibility - Health departments are to assess the target population and previous vaccination rates to accurately gauge vaccine demand [6]. - As of June 2025, 18 provinces in China have implemented policies for free HPV vaccinations or subsidies for eligible girls, laying a practical foundation for the national inclusion of the vaccine [6]. - The inclusion of the bivalent HPV vaccine in the National Immunization Program is expected to enhance vaccination rates and reduce disparities in access among different regions and income groups [6]. Group 4: Market Implications - The approval of domestic bivalent HPV vaccines from companies like Wantai Biological Pharmacy and Watson Bio is significant, as national procurement is likely to increase vaccine sales [6].